These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1750793)

  • 1. Case management of the anemic patient. Epoetin alfa: focus on dialysis efficiency.
    Latham D; Geisman J
    ANNA J; 1991 Dec; 18(6):588-9. PubMed ID: 1750793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case management of the anemic patient: epoetin alfa--focus on adequacy of dialysis.
    Erlich L
    ANNA J; 1993 Apr; 20(2):181-4. PubMed ID: 8512376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case management of the anemic patient. Epoetin alfa: focus on quality of life.
    Butera E
    ANNA J; 1992 Aug; 19(4):410-1. PubMed ID: 1520032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case management of the anemic patient. Epoetin alfa: focus on kinetic dosing.
    Keen ML
    ANNA J; 1990 Aug; 17(4):318-9. PubMed ID: 2396859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case management of the anemic patient. Epoetin alfa: focus on pediatric dialysis patients.
    Gilman C
    ANNA J; 1992 Oct; 19(5):496-7. PubMed ID: 1456798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case management of the anemic patient. Epoetin alfa: focus on inflammation and infection.
    Schardin KE
    ANNA J; 1990 Dec; 17(6):468-9. PubMed ID: 2256731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case study of the anemic patient: epoetin alfa--focus on iron management.
    Kirlin LF
    ANNA J; 1995 Apr; 22(2):192-5. PubMed ID: 7786067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoetin alfa--focus on dialyzability. Case study of the anemic patient.
    Keen ML
    ANNA J; 1995 Dec; 22(6):610-3. PubMed ID: 8633909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case study of the anemic patient: epoetin alfa--focus on exercise.
    Painter P; Carlson L
    ANNA J; 1994 May; 21(3):304-7. PubMed ID: 7998811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case management of the anemic patient: epoetin alfa--focus on cognitive function.
    Corea AL
    ANNA J; 1993 Jun; 20(3):350-3. PubMed ID: 8352632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia management in pediatric dialysis patients. Case study of the anemic patient.
    Currier H
    ANNA J; 1999 Jun; 26(3):349-52. PubMed ID: 10633609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case study of the anemic patient: epoetin alfa--focus on protocols.
    Kammerer JK
    ANNA J; 1994 Dec; 21(7):440-3. PubMed ID: 7872824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case management of the anemic patient epoetin alfa: focus on aluminum management.
    Lowrey S
    ANNA J; 1991 Feb; 18(1):56-7. PubMed ID: 2003757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Australian haemodialysis patients on intravenous epoetin alfa or intravenous darbepoetin alfa: how do they compare?
    Pussell BA; Walker R;
    Nephrology (Carlton); 2007 Apr; 12(2):126-9. PubMed ID: 17371333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case management of the anemic patient. Epoetin alfa: focus on reimbursement.
    Roe WI
    ANNA J; 1992 Apr; 19(2):198-9. PubMed ID: 1586234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive function in dialysis patients. Case study of the anemic patient.
    Martin-Lester M
    ANNA J; 1997 Jun; 24(3):359-65; quiz 366. PubMed ID: 9238909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
    Besarab A; Salifu MO; Lunde NM; Bansal V; Fishbane S; Dougherty FC; Beyer U;
    Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tools for analyzing trends in anemia management case study of the anemic patient.
    Aiello J
    Nephrol Nurs J; 2000 Feb; 27(1):57-60. PubMed ID: 10852692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.